VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $156,000 | -3.7% | 14,289 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $162,000 | -33.6% | 14,289 | -8.1% | 0.01% | -22.2% |
Q4 2021 | $244,000 | -34.6% | 15,553 | -28.5% | 0.01% | -25.0% |
Q3 2021 | $373,000 | -64.4% | 21,754 | -55.3% | 0.01% | -52.0% |
Q2 2021 | $1,047,000 | +43.2% | 48,669 | 0.0% | 0.02% | +38.9% |
Q1 2021 | $731,000 | -5.2% | 48,669 | -17.0% | 0.02% | +12.5% |
Q4 2020 | $771,000 | +88.5% | 58,651 | +135.6% | 0.02% | +77.8% |
Q4 2019 | $409,000 | +23.6% | 24,896 | 0.0% | 0.01% | +12.5% |
Q3 2019 | $331,000 | -36.1% | 24,896 | -11.6% | 0.01% | -33.3% |
Q1 2019 | $518,000 | -56.1% | 28,171 | -37.6% | 0.01% | -58.6% |
Q4 2018 | $1,180,000 | +13.8% | 45,167 | 0.0% | 0.03% | +26.1% |
Q3 2018 | $1,037,000 | +20.6% | 45,167 | 0.0% | 0.02% | +15.0% |
Q2 2018 | $860,000 | +13.0% | 45,167 | 0.0% | 0.02% | +11.1% |
Q1 2018 | $761,000 | -32.2% | 45,167 | -38.9% | 0.02% | -30.8% |
Q4 2017 | $1,123,000 | -15.1% | 73,870 | 0.0% | 0.03% | -13.3% |
Q3 2017 | $1,322,000 | – | 73,870 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |